신생아의 출생 체중에 따른 혈액 여과지 17alpha-hydroxyprogesterone의 농도 분석 및 판정 기준 조정

Analysis and Cut-off Adjustment of Dried Blood Spot 17alpha-hydroxyprogesterone Concentration by Birth Weight

  • 발행 : 2014.12.25

초록

The measurement of $17{\alpha}$-hydroxyprogesterone ($17{\alpha}$-OHP) in a dried blood spot on filter paper is an important for screening of congenital adrenal hyperplasia (CAH). Since high levels of $17{\alpha}$-OHP are frequently observed in premature infants without congenital adrenal hyperplasia, we evaluated cuts-off based on birth weight and performed validation. Birth weight and $17{\alpha}$-OHP concentration data of 292,204 newborn screening subjects in Greencross labopratories were analyzed. The cut-off values based on birth weight were newly evaluated and validated with the original data. The mean $17{\alpha}$-OHP concentration were 7.25 ng/mL in very low birth weight (VLBW) group, 4.02 ng/mL in low birth weight (LBW) group, 2.53 g/mL in normal birth weight (NBW) group, and 2.24 ng/mL in heavy birth weight (HBW) group. The cut-offs for CAH were decided as follows: 21.12 ng/mL for VLBW and LBW groups and 11.14 ng/mL for NBW and HBW groups. When applied new cut-offs for original data, positive rates in VLBW and LBW groups were decreased and positive rates in NBW and HBW groups were increased. The cut-offs based on birth weight should be used in the screening for CAH. We believe that our new cut-off reduce the false positive rate and false negative rate and our experience for cut-off set up and validation will be helpful for other laboratories doing newborn screening test.

키워드

참고문헌

  1. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-91.
  2. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-88. https://doi.org/10.1056/NEJMra021561
  3. Miller WL, Levine LS. Molecular and clinical advances in congenital adrenal hyperplasia. J Pediatr 1987;111:1-17. https://doi.org/10.1016/S0022-3476(87)80334-7
  4. Klingensmith GJ, Garcia SC, Jones HW, Migeon CJ, Blizzard RM. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 1977;90:996-1004. https://doi.org/10.1016/S0022-3476(77)80581-7
  5. Migeon CJ. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1990;70:836-7. https://doi.org/10.1210/jcem-70-4-836
  6. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab 1984;58:857-61. https://doi.org/10.1210/jcem-58-5-857
  7. Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178-82. https://doi.org/10.1056/NEJM198701223160402
  8. Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 2001;108:E68. https://doi.org/10.1542/peds.108.4.e68
  9. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 1997;130:128-33. https://doi.org/10.1016/S0022-3476(97)70321-4
  10. Kang MS, Nahm CH, Choi JW, Jeon YH, Im MW, Lee CH, Pai SH. Analysis of Blood Spot 17-Hydroxyprogesterone Concentration According to Gestational Age and Birth Weight. Korean J Clin Pathol 2001;21:104-8.
  11. Oh KI, Kim SJ, Kim DH, Kim JK, Jun YH, Choi JW, Lee JE. Revaluation of Neonatal Screening Test for Congenital Adrenal Hyperplasia. J Korean Soc Pediatr Endocrinol 2006;11:192-8.
  12. Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants-proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Paediatr Jpn 1992;34:126-33. https://doi.org/10.1111/j.1442-200X.1992.tb00938.x
  13. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogestereone levels. J Pediatr 1997;130:128-33. https://doi.org/10.1016/S0022-3476(97)70321-4